Corbus Pharmaceuticals Holdings, Inc.
NASDAQ:CRBP
6.79 (USD) • At close March 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||
| Net Income
| -40.209 | -44.603 | -42.347 | -45.64 | -111.269 | -71.454 | -55.672 | -32.422 | -19.999 | -8.851 | -2.54 | -0.602 | -0.001 |
| Depreciation & Amortization
| -2.739 | 0.641 | 1.488 | 1.639 | 1.694 | 1.23 | 0.494 | 0.256 | 0.088 | 0.044 | 0.01 | 0 | 0 |
| Deferred Income Tax
| 0 | 0 | 0 | 1.083 | 0.345 | 0 | 0.07 | -0.008 | 0.014 | 0 | 0.024 | 0 | 0 |
| Stock Based Compensation
| 6.145 | 3.47 | 5.72 | 9.48 | 12.458 | 11.982 | 7.61 | 5.694 | 3.164 | 1.153 | 0.193 | 0.006 | 0 |
| Change In Working Capital
| -5.576 | 4.094 | -4.024 | -15.696 | -3.205 | 12.476 | 17.009 | -2.23 | 3.086 | 3.008 | 0.074 | 0.165 | 0 |
| Accounts Receivables
| 0 | 0 | 0 | 1.618 | 1.063 | 5 | 12.5 | 1 | -1 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | -1.618 | -1.063 | 9.572 | 5.392 | -0.404 | 2.107 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 1.603 | 1.028 | -0.257 | -5.956 | -3.469 | 4.366 | 3.904 | -0.886 | 1.891 | 0.972 | 0.17 | 0.132 | 0 |
| Other Working Capital
| -7.179 | 3.066 | -3.767 | -9.74 | 0.264 | -6.463 | -4.787 | -1.94 | 0.089 | 2.036 | -0.096 | 0.033 | 0 |
| Other Non Cash Items
| 0.585 | 0.298 | 1.618 | 0.951 | 0.291 | 0.046 | 0.422 | 0.914 | 0.076 | -0.002 | -0.123 | 0.064 | 0 |
| Operating Cash Flow
| -41.794 | -36.1 | -37.544 | -48.184 | -99.686 | -45.721 | -30.067 | -27.797 | -13.571 | -4.647 | -2.361 | -0.367 | -0.001 |
| Investing Activities: | |||||||||||||
| Investments In Property Plant And Equipment
| 0 | 0 | -0.013 | -0.054 | -0.484 | -2.743 | -2.3 | -0.707 | -0.353 | -0.114 | -0.064 | 0 | 0 |
| Acquisitions Net
| 0 | 0 | 0.008 | 0.024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -180.804 | -33.885 | -86.342 | -87.267 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 59.494 | 69.527 | 116.421 | 13.88 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0.03 | -0.073 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| -121.31 | 35.642 | 30.074 | -73.417 | -0.484 | -2.743 | -2.3 | -0.707 | -0.353 | -0.114 | -0.064 | 0 | 0 |
| Financing Activities: | |||||||||||||
| Debt Repayment
| -15.48 | -2.874 | -0.534 | 0.058 | 18.714 | 0.358 | 0.057 | 0.057 | 0.107 | 0.018 | 0 | 0.007 | 0 |
| Common Stock Issued
| 182.058 | 0.244 | 0 | 62.586 | 142.201 | 40.677 | 12.053 | 78.892 | 16.699 | 11.329 | 10.305 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0 | -0.191 | 0 | -1.82 | -6.039 | -2.572 | -0.69 | -2.941 | -0.064 | -0.509 | -1.92 | 0.24 | 0.001 |
| Financing Cash Flow
| 166.578 | -2.821 | -0.534 | 60.823 | 154.875 | 38.463 | 11.42 | 76.008 | 16.742 | 10.837 | 8.385 | 0.127 | 0.001 |
| Other Information: | |||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 3.474 | -3.279 | -8.004 | -60.777 | 54.705 | -10 | -20.948 | 47.504 | 2.818 | 6.076 | 5.959 | -0.239 | 0 |
| Cash At End Of Period
| 17.868 | 14.394 | 17.673 | 25.677 | 86.453 | 31.749 | 41.748 | 62.696 | 15.192 | 12.338 | 6.262 | 0.303 | 0.001 |